[
  {
    "ts": null,
    "headline": "Goldman Sachs adds Burlington, removes Amgen from Conviction List",
    "summary": "Burlington Stores (BURL) and Air Lease (AL) are the latest additions to Goldman Sachs' US Conviction List, while Amgen (AMGN) and Global-E Online (GLBE) are out. Goldman Sachs Director of Americas Equity Research Steve Kron comes on to talk more about these picks and the selection process for the firm's conviction list. \"Consumers are in a really good spot to spend. So you think about the off-price retailers — they're they're in that sweet spot of consumers that are seeking value right now,\" Kron tells Catalysts hosts Seana Smith and Madison Mills. \"Also higher income consumers that are looking to trade down for good brands and Burlington's been executing really well.\" On tech giant Nvidia (NVDA), Kron is seeing the AI revolution entering its \"infrastructure build-out stage\" while more companies like Salesforce (CRM) are beginning to deploy their artificial intelligence products. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Luke Carberry Mogan.",
    "url": "https://finnhub.io/api/news?id=786f33dddddc58a9acbaddac6c55d28142bb10364d08bcc9d73f14c9cf0e9f19",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733768100,
      "headline": "Goldman Sachs adds Burlington, removes Amgen from Conviction List",
      "id": 131871872,
      "image": "https://s.yimg.com/ny/api/res/1.2/giAPbeCgkStxU5RELhr2WA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2024-12/3455a1b0-b654-11ef-97e6-4a50586f3806",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Burlington Stores (BURL) and Air Lease (AL) are the latest additions to Goldman Sachs' US Conviction List, while Amgen (AMGN) and Global-E Online (GLBE) are out. Goldman Sachs Director of Americas Equity Research Steve Kron comes on to talk more about these picks and the selection process for the firm's conviction list. \"Consumers are in a really good spot to spend. So you think about the off-price retailers — they're they're in that sweet spot of consumers that are seeking value right now,\" Kron tells Catalysts hosts Seana Smith and Madison Mills. \"Also higher income consumers that are looking to trade down for good brands and Burlington's been executing really well.\" On tech giant Nvidia (NVDA), Kron is seeing the AI revolution entering its \"infrastructure build-out stage\" while more companies like Salesforce (CRM) are beginning to deploy their artificial intelligence products. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Luke Carberry Mogan.",
      "url": "https://finnhub.io/api/news?id=786f33dddddc58a9acbaddac6c55d28142bb10364d08bcc9d73f14c9cf0e9f19"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. stock outperforms competitors on strong trading day",
    "summary": "Amgen Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=37eb4c62142029bbe6d51e537e67d2ff3a5543de9691dacab42206ed619e5810",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733762340,
      "headline": "Amgen Inc. stock outperforms competitors on strong trading day",
      "id": 131935366,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=37eb4c62142029bbe6d51e537e67d2ff3a5543de9691dacab42206ed619e5810"
    }
  },
  {
    "ts": null,
    "headline": "2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer",
    "summary": "Whether you're looking for a way to beat the benchmark S&P 500 index or you just want a steady flow of passive income, dividend-paying stocks are a great way to achieve your investment goals.  During the 50-year period that ended in 2023, dividend-paying stocks in the S&P 500 index delivered a 9.17% average annual return.  At recent prices, shares of Coca-Cola (NYSE: KO), and Amgen (NASDAQ: AMGN) offer dividend yields above 3%, plus there's a good chance they'll be able to raise their payouts for many years to come.",
    "url": "https://finnhub.io/api/news?id=673bb4fec35823c70ae3d9c03ee798b48f8327396c25c5bb90e48c482d220dc9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733736960,
      "headline": "2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer",
      "id": 131868018,
      "image": "https://g.foolcdn.com/editorial/images/800186/investment-presentation2-getty.jpg",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Whether you're looking for a way to beat the benchmark S&P 500 index or you just want a steady flow of passive income, dividend-paying stocks are a great way to achieve your investment goals.  During the 50-year period that ended in 2023, dividend-paying stocks in the S&P 500 index delivered a 9.17% average annual return.  At recent prices, shares of Coca-Cola (NYSE: KO), and Amgen (NASDAQ: AMGN) offer dividend yields above 3%, plus there's a good chance they'll be able to raise their payouts for many years to come.",
      "url": "https://finnhub.io/api/news?id=673bb4fec35823c70ae3d9c03ee798b48f8327396c25c5bb90e48c482d220dc9"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Eli Lilly, Novo Nordisk's  Amgen and Viking Therapeutics",
    "summary": "Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=423ce408badc38de851bc3fce6f8b77f20f5882cc5af1ff7b42397e67687a4dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733727060,
      "headline": "The Zacks Analyst Blog Eli Lilly, Novo Nordisk's  Amgen and Viking Therapeutics",
      "id": 131867971,
      "image": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=423ce408badc38de851bc3fce6f8b77f20f5882cc5af1ff7b42397e67687a4dd"
    }
  }
]